Obesity-oriented therapeutic compounds such as Sodium-Glucose Cotransporter-2 (SGLT2), statins and metformin all show tumor growth inhibitory effects, and reverse obesity-driven cancer aggressiveness [10,11,12]. The gene discussed is SLC5A2; the disease is cancer.